Login / Signup

Outcomes of initial and repeat micro-pulse transscleral cyclophotocoagulation in adult glaucoma patients.

Sara J HooshmandJackson VossMatthew HirabayashiLindsey McDanielJella An
Published in: Therapeutic advances in ophthalmology (2022)
MP-TSCPC is a safe and effective non-invasive means to lower IOP in a variety of glaucoma patients. While over 50% (34/67) of eyes required repeat MP-TSCPC, repeat treatment resulted in greater success rates and IOP reduction without any adverse events when using the total energy between 112 and 150 J.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • peritoneal dialysis
  • patient reported outcomes
  • skeletal muscle
  • insulin resistance